Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina

Journal of Clinical Microbiology

Volumn 43, Issue 2, 2005, Pages 802-807

  Lopardo, Horacio A ^a,f   Vidal, Patricia ^a   Sparo, Monica ^b   Jeric, Paola ^a   Centron, Daniela ^a   Facklam, Richard R ^d   Paganini, Hugo ^a   Pagniez, N Gaston ^c   Lovgren, Marguerite ^e   Beall, Bernard ^d  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Hospital R Santamarina   (Argentina)

^c Hospital Pirovano   (Argentina)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^f HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; MIKAMYCIN B; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SEQUENCE ANALYSIS; SEROPREVALENCE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARGENTINA; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A'; STREPTOCOCCUS SP. 'GROUP G';

EID: 20844442763     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.2.802-807.2005     Document Type: Article

References (33)

1. Ayoub, E. M., and S. Ahmed. 1997. Update on complications of group A streptococcal infections. Curr. Probl. Pediatr. 27:90-101.
2. Beall, B., G. Gherardi, M. Lovgren, B. Forwick, R. Facklam, and G. Tyrrell. 2000. emm and sof gene sequence variation in relation to serological typing of opacity factor positive group A streptococci. Microbiology 146:1195-1209.
3. Beall, B., R. R. Facklam, J. A. Elliott, A. R. Franklin, T. Hoenes, D. Jackson, L. Laclaire, T. Thompson, and R. J. Viswanathan. 1998. Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci. Med. Microbiol. 47:893-898.
4. Bingen, E., R. Leclercq, F. Fitoussi, N. Brahimi, B. Malbruny, D. Deforche, and R. Cohen. 2002. Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob. Agents Chemother. 46:1199-1203.
5. Bisno, A. L., C. M. Collins, and J. C. Turner. 1996. M proteins of group C streptococci isolated from patients with acute pharyngitis. J. Clin. Microbiol. 34:2511-2515.
6. Brandt, C. M., G. Haase, N. Schnitzler, R. Zbinden, and R. Lutticken. 1999. Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen. J. Clin. Microbiol. 37: 4194-4197.
7. Campo, R. E., D. R. Schultz, and A. L. Bisno. 1995. M proteins of group G streptococci: mechanisms of resistance to phagocytosis. J. Infect. Dis. 171: 601-606.
8. Facklam, R., B. Beall, A. Efstratiou, V. Fischetti, D. Johnson, E. Kaplan, P. Kriz, M. Lovgren, D. Martin, B. Schwartz, A. Totolian, D. Bessen, S. Hollingshead, F. Rubin, J. Scott, and G. Tyrrell. 1999. Emm typing and validation of provisional M types for group A streptococci. Emerg. Infect. Dis. 5:247-253.
9. Galimand, M., T. Lambert, G. Gerbaud, and P. Courvalin. 1999. High-level aminoglycoside resistance in the beta-hemolytic group G Streptococcus isolate BM2721. Antimicrob. Agents Chemother. 43:3008-3010.
10. Gaviria, J. M., and A. L. Bisno. 2000. Group C and G streptococci. p. 238-254. in D. L. Stevens, and E. L. Kaplan (ed.), Streptococcal infections: clinical aspects, microbiology and molecular pathogenesis. Oxford University Press, New York, N.Y.
11. Haidan, A., S. R. Talay, M. Rohde, K. S. Sriprakash, B. J. Currie, and G. S. Chhatwal. 2000. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an aboriginal population. Lancet 356:1167-1169.
12. Hu, M. C., M. A. Walls, S. D. Stroop, M. A. Reddish, B. Beall, and J. B. Dale. 2002, Immunogenicity of a 26-valent group A streptococcal vaccine. Infect. Immun. 70:2171-2177.
13. Igwe, E. I., P. L. Shewmaker, R. R. Facklam, M. M. Farley, C. van Beneden, and B. Beall. 2003. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett. 229:259-264.
14. Jeric, P., H. Lopardo, P. Vidal, S. Arduino, A. Fernández., B. E. Orman, D. O. Sordelli, and D. Centrón. 2002. Multicenter study on spreading of the tet(M) gene in tetracycline resistant Streptococcus group G and C isolates in Argentina. Antimicrob. Agents Chemother. 46:239-241.
15. Kalia, A., and D. E. Bessen. 2003. Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. FEMS Microbiol. Lett. 219:291-295.
16. Kaplan, E. L., E. A. Kreutzer, C. Viegas, and R. Cuttica. 1985. Estreptococos beta-hemolíticos aislados en Buenos Aires y su relevancia en la epidemiologia de las infecciones estreptocócicas, fiebre reumática y glomerulonefritis aguda. Rev. Latina Card. Infect. 1:246-251.
17. Kataja, J., H. Seppala, M. Skurnik, H. Sarkkinen, and P. Huovinen P. 1998. Different erythromycin resistance mechanism in group C and group G streptococci. Antimicrob. Agents Chemother. 42:1493-1494.
18. Keiser, P., and W. Campbell. 1992. Toxic strep syndrome associated with group C streptococcus. Arch. Intern. Med. 152:882-883.
19. Li, Z., V. Sakota, D. Jackson, A. R. Franklin, and B. Beall. 2003. Array of M protein gene subtypes in 1064 recent invasive group A streptococcal isolates recovered from the Active Bacterial Core Surveillance. J. Infect. Dis. 188: 1587-1592.
20. Lopardo, H. A., M. E. Venuta, P. Vidal, L. Rosaenz, C. Corthey, A. Farinati, E. Couto, B. Sarachian, M. Sparo, S. Kaufman, C. A. De Mier, L. Gubbay, V. Scilingo, P. Villaverde, and The Argentinian Streptococcus Study Group. 1997. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. Diagn. Microbiol. Infect. Dis. 28:29-32.
21. Lopardo, H. A., P. Vidal, P. Jeric, D. Centrón, H. Paganini, R. R. Facklam, the Argentinian Streptococcus Study Group, and J. Elliott. 2003. Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J. Clin. Microbiol. 41:4688-4694.
22. McMurry, L. M., and S. B. Levy. 2000. Tetracycline resistance in gram-positive bacteria, p. 660-677. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. ASM Press, Washington, D.C.
23. Murray, I. A. 2000. Chloramphenicol resistance, p. 678-684. In V. A. Fischetti, R. P.Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. ASM Press, Washington, D.C.
24. National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility test. Approved standard M2-A7, 7th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
25. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, 5th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
26. O'Brien, K. L., B. Beall, N. L. Barrett, P. R. Cieslak, A. Reingold, M. M. Parley, R. Danila, E. R. Zell, R. Facklam, B. Schwartz, and A. Schuchat. 2002. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:268-276.
27. Sahm, D. F., and C. Torres. 1988. High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis. J. Clin. Microbiol. 26:257-260.
28. Seppälä, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
29. Seppälä, H., A. Nissinen, H. Järvinen, S. Huovinen, T. Henriksson, E. Herva, S. E. Holm, M. Jahkola, M. L. Katila, T. Klaukka, S. Kontiainen, O. Liimatainen, S. Oinonen, L. Passi-Metsomaa, and P. Huovinen. 1992. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292-297.
30. Soriano, S. V., S. Brasili, M. Saiz, C. Carranza, P. Vidal, J. Calderón, and H. Lopardo. 2000. Streptococcus pyogenes: sensibilidad a penicilina y eritromicina en las ciudades de Neuquén y Cipolletti. Medicina (Buenos Aires) 60:487-490.
31. Stevens, D. L. 1995. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg. Infect. Dis. 1:69-78.
32. Tyrrell, G. T., M. Lovgren, B. Forwick, N. P. Hoe, J. M. Musser, and J. A. Talbot. 2002. M types of group A streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J. Clin. Microbiol. 40:4466-4471.
33. Van Asselt, G. J., J. S. Vliegenthart, J. A. van de Klundert, and R. P. Mouton. 1992. High-level aminoglycoside resistance among enterococci and group A streptococci. J. Antimicrob. Chemother. 30:651-659.